+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Psoriasis Market and Competitive Landscape - 2020

  • ID: 5023520
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Psoriasis Market and Competitive Landscape - 2020, provides comprehensive insights into the Psoriasis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Psoriasis market size and drug sales. It also provides insights into Psoriasis epidemiology and late stage pipeline.

This research covers the following: Psoriasis treatment options, Psoriasis late stage clinical trials pipeline, Psoriasis prevalence by countries, Psoriasis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Psoriasis pipeline: Find out drugs in clinical trials for the treatment of Psoriasis by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Psoriasis epidemiology: Find out the number of patients diagnosed (prevalence) with Psoriasis by countries
  • Psoriasis drugs: Identify key drugs marketed and prescribed for Psoriasis in the US, including trade name, molecule name, and company
  • Psoriasis drugs sales: Find out the sales value for Psoriasis drugs by countries
  • Psoriasis market valuations: Find out the market size for Psoriasis drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Psoriasis drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Psoriasis drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Psoriasis market
  • Develop in-depth knowledge of competition and markets
  • Analyze Psoriasis drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Psoriasis market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Psoriasis Treatment Options

2. Psoriasis Pipeline Insights
2.1. Psoriasis Phase 3 Clinical Trials
2.2. Psoriasis Phase 2 Clinical Trials
2.3. Psoriasis Phase 1 Clinical Trials

3. Psoriasis Epidemiology Analysis by Countries

4. Germany Psoriasis Market Insights
4.1. Marketed Drugs for Psoriasis in Germany
4.2. Germany Psoriasis Market Size & Forecast
4.3. Germany Psoriasis Drugs Sales Forecast
4.4. Germany Psoriasis Market Share Analysis

5. France Psoriasis Market Insights
5.1. Marketed Drugs for Psoriasis in France
5.2. France Psoriasis Market Size & Forecast
5.3. France Psoriasis Product Sales Forecast
5.4. France Psoriasis Market Share Analysis

6. Italy Psoriasis Market Insights
6.1. Marketed Drugs for Psoriasis in Italy
6.2. Italy Psoriasis Market Size & Forecast
6.3. Italy Psoriasis Product Sales Forecast
6.4. Italy Psoriasis Market Share Analysis

7. Spain Psoriasis Market Insights
7.1. Marketed Drugs for Psoriasis in Spain
7.2. Spain Psoriasis Market Size & Forecast
7.3. Spain Psoriasis Product Sales Forecast
7.4. Spain Psoriasis Market Share Analysis

8. UK Psoriasis Market Insights
8.1. Marketed Drugs for Psoriasis in UK
8.2. UK Psoriasis Market Size & Forecast
8.3. UK Psoriasis Product Sales Forecast
8.4. UK Psoriasis Market Share Analysis

9. Europe Psoriasis Market Insights
9.1. Europe Psoriasis Market Size & Forecast
9.2. Europe Psoriasis Product Sales Forecast
9.3. Europe Psoriasis Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Psoriasis Phase 3 Clinical Trials, Global, 2020
Table 2: Psoriasis Phase 2 Clinical Trials, Global, 2020
Table 3: Psoriasis Phase 1 Clinical Trials, Global, 2020
Table 4: Psoriasis Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Psoriasis in Germany, 2019
Table 6: Germany Psoriasis Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Psoriasis Product Sales ($mn), 2016 - 2024
Table 8: Germany Psoriasis Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Psoriasis in France, 2019
Table 10: France Psoriasis Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Psoriasis Product Sales ($mn), 2016 - 2024
Table 12: France Psoriasis Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Psoriasis in Italy, 2019
Table 14: Italy Psoriasis Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Psoriasis Product Sales ($mn), 2016 - 2024
Table 16: Italy Psoriasis Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Psoriasis in Spain, 2019
Table 18: Spain Psoriasis Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Psoriasis Product Sales ($mn), 2016 - 2024
Table 20: Spain Psoriasis Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Psoriasis in UK, 2019
Table 22: UK Psoriasis Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Psoriasis Product Sales ($mn), 2016 - 2024
Table 24: UK Psoriasis Market Events and Trends, 2016 - 2024
Table 25: Europe Psoriasis Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Psoriasis Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Psoriasis Pipeline by Phase (%), Global, 2020
Figure 2: Psoriasis Prevalence by Countries, 2016 - 2024
Figure 3: Germany Psoriasis Market Size ($mn), 2016 - 2024
Figure 4: Germany Psoriasis Product Sales ($mn), 2016 - 2024
Figure 5: Germany Psoriasis Market Share by Drugs (%), 2019
Figure 6: Germany Psoriasis Market - Future Market Share (%), 2024
Figure 7: France Psoriasis Market Size ($mn), 2016 - 2024
Figure 8: France Psoriasis Product Sales ($mn), 2016 - 2024
Figure 9: France Psoriasis Market Share by Drugs (%), 2019
Figure 10: France Psoriasis Market - Future Market Share (%), 2024
Figure 11: Italy Psoriasis Market Size ($mn), 2016 - 2024
Figure 12: Italy Psoriasis Product Sales ($mn), 2016 - 2024
Figure 13: Italy Psoriasis Market Share by Drugs (%), 2019
Figure 14: Italy Psoriasis Market - Future Market Share (%), 2024
Figure 15: Spain Psoriasis Market Size ($mn), 2016 - 2024
Figure 16: Spain Psoriasis Product Sales ($mn), 2016 - 2024
Figure 17: Spain Psoriasis Market Share by Drugs (%), 2019
Figure 18: Spain Psoriasis Market - Future Market Share (%), 2024
Figure 19: UK Psoriasis Market Size ($mn), 2016 - 2024
Figure 20: UK Psoriasis Product Sales ($mn), 2016 - 2024
Figure 21: UK Psoriasis Market Share by Drugs (%), 2019
Figure 22: UK Psoriasis Market - Future Market Share (%), 2024
Figure 23: Europe Psoriasis Market Size ($mn), 2016 - 2024
Figure 24: Europe Psoriasis Product Sales ($mn), 2016 - 2024
Figure 25: Europe Psoriasis Market Share by Drugs (%), 2019
Figure 26: Europe Psoriasis Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll